The Commission shall conclude contracts with selected manufacturers in order to manage, for category A diseases as referred to in Article 3 of Commission Implementing Regulation (EU) 2022/140, the following banks:
Union antigen banks;
Union vaccine banks;
Union diagnostic reagent banks.
The Commission shall implement a public procurement procedure, in accordance with the rules laid down in Regulation (EU, Euratom) 2018/1046, for the selection of the manufacturers for the contracts referred to in paragraph 1.
The contracts referred to in paragraph 1 shall cover at least the following matters:
conditions for the supply of various quantities and types of antigens, vaccines or diagnostic reagents to the Union antigen, vaccine and diagnostic reagent banks;
conditions for the secure storage and replacement of antigens, vaccines or diagnostic reagents;
in the case of Union antigen banks, guarantees and conditions for:
the rapid formulation of the antigens into vaccines;
the production, bottling and labelling of vaccines reconstituted from the antigens;
conditions for the release, shipment and delivery of vaccines or diagnostic reagents;
conditions for the destruction and safe disposal of the antigens, vaccines or diagnostic reagents, or for the buy-back of antigens, for which the validity period has expired.